Literature DB >> 15975949

Polyneuropathy in POEMS syndrome: role of angiogenic factors in the pathogenesis.

Marina Scarlato1, Stefano Carlo Previtali, Marinella Carpo, Davide Pareyson, Chiara Briani, Roberto Del Bo, Eduardo Nobile-Orazio, Angelo Quattrini, Giacomo Pietro Comi.   

Abstract

In order to clarify the role of angiogenic factors in polyneuropathy of POEMS (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes) syndrome, we measured the serum concentrations of vascular endothelial growth factor (VEGF) and erythropoietin (EPO) in 11 patients and correlated these with VEGF and EPO peripheral nerve expression and the degree of endoneurial vessel involvement. We found that POEMS syndrome was associated with high levels of serum VEGF and, conversely, low levels of serum EPO. Similarly, in POEMS nerves VEGF was highly expressed in blood vessels and some non-myelin-forming Schwann cells. In contrast, the expression of VEGF receptor 2 was down-regulated compared with that in normal nerves. Both EPO and EPO receptor were localized to the nerve vasculature and were expressed to similar extents in normal and POEMS nerves. The inverse correlation between VEGF and EPO serum levels was maintained during the clinical course; however, both levels returned to normal when there was a response to therapy. High serum VEGF, low serum EPO and high peripheral nerve VEGF were all associated with more severe endoneurial vessel involvement and nerve damage. Light microscopy showed an increased thickness of the basal lamina and a narrowing of the lumina of endoneurial vessels in POEMS samples, while proliferation of endothelial cells and opening of tight junctions were observed by electron microscopy. The present data support the role of angiogenic factors as diagnostic and prognostic markers of POEMS syndrome. They also suggest that VEGF and EPO are involved in the pathogenesis of polyneuropathy. In conclusion, establishing the role of angiogenic factors in polyneuropathy may lead to a better understanding of the effects of VEGF and EPO on microangiopathy and Schwann cell function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15975949     DOI: 10.1093/brain/awh519

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  47 in total

1.  Expression of vascular endothelial growth factor by plasma cells in the sclerotic bone lesion of a patient with POEMS syndrome.

Authors:  Hideto Nakajima; Shimon Ishida; Daisuke Furutama; Masakazu Sugino; Fumiharu Kimura; Taiji Yokote; Ichiro Baba; Motomu Tsuji; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2007-02-03       Impact factor: 4.849

2.  Papilloedema is an independent prognostic factor for POEMS syndrome.

Authors:  Rongtai Cui; Shengyuan Yu; Xusheng Huang; Jiatang Zhang; Chenglin Tian; Chuanqiang Pu
Journal:  J Neurol       Date:  2013-10-20       Impact factor: 4.849

3.  Ischemic stroke as clinical onset of POEMS syndrome.

Authors:  P Dacci; F Lessi; E Dalla Bella; M Morbin; C Briani; G Lauria
Journal:  J Neurol       Date:  2013-11-13       Impact factor: 4.849

4.  A special subtype of POEMS syndrome: IgG4 subtype.

Authors:  Miao Zheng; Pan Zhou; Kai Zheng; Li Meng; Xian Liu; Mengdi Chu; Jie Lu; Lingli Dong
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

5.  Somatic Mutations Confer Severe Peripheral Neuropathy in POEMS Syndrome-Associated Multicentric Castleman Disease.

Authors:  Qingqing Lin; Juying Wei; Jiejing Qian; Liangshun You; Wenbin Qian
Journal:  Neurosci Bull       Date:  2020-03-12       Impact factor: 5.203

6.  Castleman disease variant of POEMS syndrome complicated with multiple cerebral infarction: a rare case report and review of literature.

Authors:  Hang Yu; Fang Yao; Yue Li; Jian Li; Quan-Cai Cui
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

7.  Ischemic stroke in patients with POEMS syndrome.

Authors:  Jun Feng; Xue-Min Gao; Hao Zhao; Tian-Hua He; Cong-Li Zhang; Kai-Ni Shen; Lu Zhang; Xin-Xin Cao; Ming Qian; Dao-Bin Zhou; Jian Li
Journal:  Blood Adv       Date:  2020-07-28

8.  Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.

Authors:  Satish Chandrashekaran; Angela Dispenzieri; Stephen S Cha; Cassie C Kennedy
Journal:  Respir Med       Date:  2014-11-14       Impact factor: 3.415

9.  Erythropoietin: a multimodal neuroprotective agent.

Authors:  Nadiya Byts; Anna-Leena Sirén
Journal:  Exp Transl Stroke Med       Date:  2009-10-21

10.  Intracranial hemangiomas in a patient with POEMS syndrome.

Authors:  G D Maurer; J Schittenhelm; U Ernemann; V A J Kempf; R Ritz; M Weller; F Schmidt
Journal:  J Neurol       Date:  2009-11-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.